Company intelligence / Profile preview

Revvity

Waltham, Massachusetts, United Statesrevvity.com ↗

Ownership: Public · RVTY
Employees: ~11000
Development stage: Commercial

Overview

Revvity delivers commercial-stage life science tools and diagnostic solutions globally. It does not have clinical trial results as it does not develop therapeutics but enables scientific discovery to diagnosis with its technologies. Its products are widely cited in peer-reviewed publications and used by leading pharma/biotech companies.

Therapeutic areas: Metabolic DisordersImmunologyInfectious Diseases
Modalities: ReagentsAssaysInstrumentsSoftware solutions for informatics and data management
Industry: Drug Discovery Services

Financials

Market cap: $13.5B
Total revenue: $729.7M
Enterprise value: $15.8B

Beyond the preview

Go deeper on Revvity.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Revvity.

Explore the full profile